PubRank

J E Maggio

Author PubWeight™ 67.54‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alzheimer's disease amyloid propagation by a template-dependent dock-lock mechanism. Biochemistry 2000 2.37
2 The Alzheimer's peptide a beta adopts a collapsed coil structure in water. J Struct Biol 2000 2.26
3 Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995 2.12
4 Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci U S A 1988 1.87
5 Purification and characterization of chlorotoxin, a chloride channel ligand from the venom of the scorpion. Am J Physiol 1993 1.77
6 Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998 1.68
7 Amyloid beta-peptide is transported on lipoproteins and albumin in human plasma. J Biol Chem 1996 1.61
8 Rapid endocytosis of a G protein-coupled receptor: substance P evoked internalization of its receptor in the rat striatum in vivo. Proc Natl Acad Sci U S A 1995 1.60
9 Point substitution in the central hydrophobic cluster of a human beta-amyloid congener disrupts peptide folding and abolishes plaque competence. Biochemistry 1996 1.58
10 Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry 1998 1.54
11 A beta deposition inhibitor screen using synthetic amyloid. Nat Biotechnol 1997 1.37
12 Novel peptide fragments originating from PGLa and the caerulein and xenopsin precursors from Xenopus laevis. J Biol Chem 1986 1.30
13 Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989 1.27
14 Deposition of monomeric, not oligomeric, Abeta mediates growth of Alzheimer's disease amyloid plaques in human brain preparations. Biochemistry 1999 1.27
15 Activation barriers to structural transition determine deposition rates of Alzheimer's disease a beta amyloid. J Struct Biol 2000 1.20
16 In vitro growth of Alzheimer's disease beta-amyloid plaques displays first-order kinetics. Biochemistry 1996 1.19
17 Aluminum, iron, and zinc ions promote aggregation of physiological concentrations of beta-amyloid peptide. J Neurochem 1993 1.19
18 Synaptic relationship between substance P and the substance P receptor: light and electron microscopic characterization of the mismatch between neuropeptides and their receptors. Proc Natl Acad Sci U S A 1994 1.19
19 Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol 1995 1.19
20 Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci U S A 1989 1.15
21 Photoaffinity cross-linking of Alzheimer's disease amyloid fibrils reveals interstrand contact regions between assembled beta-amyloid peptide subunits. Biochemistry 2001 1.14
22 Intestinal absorption and excretion of octapeptides composed of D amino acids. Proc Natl Acad Sci U S A 1994 1.08
23 Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 1995 1.06
24 Pharmacological analysis of [3H]-senktide binding to NK3 tachykinin receptors in guinea-pig ileum longitudinal muscle-myenteric plexus and cerebral cortex membranes. Br J Pharmacol 1990 1.02
25 Intra-arterial infusion of [125I]A beta 1-40 labels amyloid deposits in the aged primate brain in vivo. Neuroreport 1996 1.01
26 Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides 1989 0.99
27 Delayed behavioral effects following intrahippocampal injection of aggregated A beta (1-42). Brain Res 1999 0.98
28 Absorption and excretion of undegradable peptides: role of lipid solubility and net charge. J Pharmacol Exp Ther 1997 0.96
29 Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease. Neuroscience 1988 0.93
30 Substance P receptors: localization by light microscopic autoradiography in rat brain using [3H]SP as the radioligand. Brain Res 1984 0.92
31 Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembranous colitis. Dig Dis Sci 1996 0.91
32 Regional distribution of kassinin-like immunoreactivity in rat central and peripheral tissues and the effect of capsaicin. Brain Res 1984 0.91
33 The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain. Eur J Pharmacol 1984 0.90
34 Differential expression of two isoforms of the neurokinin-1 (substance P) receptor in vivo. Brain Res 1996 0.90
35 Mapping peptide-binding domains of the substance P (NK-1) receptor from P388D1 cells with photolabile agonists. J Biol Chem 1995 0.88
36 A study of tachykinin-immunoreactive neurons in monkey cerebral cortex. J Neurosci 1988 0.87
37 Substance P and substance K receptor binding sites in the human gastrointestinal tract: localization by autoradiography. Peptides 1989 0.87
38 Beta 2-adrenergic receptors are expressed by glia in vivo in the normal and injured central nervous system in the rat, rabbit, and human. J Neurosci 1995 0.87
39 The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes. Peptides 1988 0.87
40 Stereochemical specificity of Alzheimer's disease beta-peptide assembly. Biopolymers 1999 0.86
41 Zinc-induced aggregation of human and rat beta-amyloid peptides in vitro. J Neurochem 1996 0.86
42 A novel radioimmunoassay for neuromedin K. I. Absence of neuromedin K-like immunoreactivity in guinea pig ileum and urinary bladder. II. Heterogeneity of tachykinins in guinea pig tissues. Regul Pept 1989 0.85
43 Receptor binding sites for cholecystokinin, galanin, somatostatin, substance P and vasoactive intestinal polypeptide in sympathetic ganglia. Neuroscience 1992 0.85
44 Pharmacological characterisation of a novel tachykinin isolated from mammalian spinal cord. Eur J Pharmacol 1984 0.84
45 Local anesthetics inhibit substance P binding and evoked increases in intracellular Ca2+. Anesthesiology 1995 0.84
46 Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK-1 receptors. Neurosci Lett 1994 0.82
47 Evidence for vasoactive intestinal polypeptide as a neurotransmitter in smooth muscle of the urogenital tract. Brain Res 1984 0.82
48 Agonist-induced photoincorporation of a p-benzoylphenylalanine derivative of substance P into membrane-spanning region 2 of the Torpedo nicotinic acetylcholine receptor delta subunit. Mol Pharmacol 1994 0.82
49 Expression of endothelin-B receptors by glia in vivo is increased after CNS injury in rats, rabbits, and humans. Exp Neurol 1997 0.81
50 Structure of a mycobacterial polysaccharide-fatty acyl-CoA complex: nuclear magnetic resonance studies. Proc Natl Acad Sci U S A 1980 0.81
51 Neuropeptide Y/peptide YY receptor binding sites in the heart: localization and pharmacological characterization. Neuroscience 1993 0.81
52 Mild footshock stress dissociates substance P from substance K and dynorphin from Met- and Leu-enkephalin. Brain Res 1986 0.80
53 Substance K and substance P in the ventral tegmental area. Neurosci Lett 1985 0.80
54 Substance K and substance P differentially modulate mesolimbic and mesocortical systems. Peptides 1985 0.80
55 Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors. Methods Enzymol 1999 0.80
56 "Kassinin" in mammals: the newest tachykinins. Peptides 1985 0.79
57 A pharmacological study with substance K: evidence for multiple types of tachykinin receptors. Eur J Pharmacol 1984 0.78
58 Zinc and Alzheimer's disease. Science 1995 0.77
59 Substance P receptors on canine chief cells: localization, characterization, and function. J Neurosci 1989 0.77
60 New insights into the neuropathology and cell biology of Alzheimer's disease. Geriatrics 1997 0.77
61 Alterations in receptors for sensory neuropeptides in human inflammatory bowel disease. Adv Exp Med Biol 1991 0.77
62 Immunocytochemical localization of neuromedin K (neurokinin B) in rat spinal ganglia and cord. Peptides 1991 0.77
63 Heterogeneity of tachykinin-like immunoreactive peptides in rat spinal cord and dorsal root ganglia. Peptides 1989 0.76
64 p-(4-Hydroxybenzoyl)phenylalanine: a photoreactive amino acid analog amenable to radioiodination for elucidation of peptide-protein interaction. Application to substance P receptor. Biochemistry 1997 0.75
65 The localization and characterization of substance P and substance K in striatonigral neurons. Brain Res 1986 0.75
66 Development of a novel probe for measuring drug binding to the F1*S variant of human alpha 1-acid glycoprotein. J Pharm Sci 2001 0.75
67 The regional distribution of kassinin-like immunoreactivity in central and peripheral tissues of the cat. Brain Res 1985 0.75
68 Simultaneous extraction of total RNA and peptides from tissues: application to tachykinins. Peptides 1995 0.75